首页> 外文OA文献 >Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)

【2h】

Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)

机译：随机期II研究二线化疗，具有最佳5-氟尿嘧啶方案与早期胃癌的每周施用紫杉醇，具有严重的腹膜转移耐火至含5氟尿嘧啶的方案（JCOG0407）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Tomohiro Nishina; Narikazu Boku; Masahiro Gotoh; Yasuhiro Shimada; Yasuo Hamamoto; Hirofumi Yasui; Kensei Yamaguchi; Hiroki Kawai; Norisuke Nakayama; Kenji Amagai; Junki Mizusawa; Kenichi Nakamura; Kuniaki Shirao; Atsushi Ohtsu;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407) [J] . Nishina Tomohiro, Boku Narikazu, Gotoh Masahiro, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2016,第3期

机译：在最佳晚期胃癌伴有5-氟尿嘧啶治疗难以治愈的严重腹膜转移的晚期胃癌中，采用最佳的5-氟尿嘧啶治疗方案与每周一次给予紫杉醇的二线化疗随机II期研究（JCOG0407）
2. Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer [J] . Kim Jin Young, Ryoo Hun Mo, Bae Sung Hwa, Anticancer Research: International Journal of Cancer Research and Treatment . 2015,第6期

机译：多西紫杉醇与每周多西紫杉醇加奥沙利铂作为晚期胃癌患者二线化疗的多中心随机II期研究
3. Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9 [J] . Abraham Jame, Robidoux Andr, Tan Antoinette R., Breast cancer research and treatment. . 2015,第2期

机译：NSABP基金会研究FB-9，评估II期随机临床试验，评估每周辅助用紫杉醇或艾瑞布林联合阿霉素和环磷酰胺的新辅助化疗方案对局部晚期HER2阴性乳腺癌妇女的作用
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group [O] . Kenro Hirata, Yasuo Hamamoto, Masahiko Ando, 2020

机译：每周紫杉醇联合雷莫昔单抗与每周纳布紫杉醇联合雷莫西单抗治疗无法切除的晚期或复发性胃癌但一线治疗难治性腹膜扩散-P-SELECT试验（WJOG10617G）-西日本肿瘤学小组的一项随机II期试验
6. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group [O] . Kenro Hirata, Yasuo Hamamoto, Masahiko Ando, 2020

机译：每周Paclitaxel Plus Ramucirumab与每周Nab-Paclitaxel加上Ramucirumab与腹膜传播难以进行一线治疗 - P-SELECT试验（WJOG10617G）-A由西日本肿瘤学组进行随机化第二次审判

Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)

著录项

相似文献

相关主题

期刊订阅